MedTrace Logo

GAPP 2 Survey: Global Attitudes of Patients and Physicians in Insulin Therapy for Type 2 Diabetes Mellitus

NCT01950637 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2017-01-13

No results posted yet for this study

Summary

This study is conducted Asia, Europe and North America. The aim of this study is to describe insulin therapy adherence and the burden of non-adherence on patient functioning, well-being and diabetes management.

Conditions

Interventions

BEHAVIORAL

No treatment given

Completion of 90-item online questionnaire.

BEHAVIORAL

survey

Completion of 58-item online questionnarie.

Sponsors & Collaborators

Principal Investigators

  • Global Clinical Registry (GCR, 1452) · Novo Nordisk A/S

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • United States
  • Canada
  • Denmark
  • Germany
  • Japan
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01950637 on ClinicalTrials.gov